Connor, Clark & Lunn Investment Management Ltd. Roivant Sciences Ltd. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
SELL
$9.87 - $11.8 $5.2 Million - $6.21 Million
-526,410 Reduced 58.56%
372,556 $3.93 Million
Q4 2023

Feb 09, 2024
BUY
$8.38 - $11.58 $1.01 Million - $1.39 Million
120,001 Added 15.41%
898,966 $10.1 Million
Q3 2023

Nov 13, 2023
BUY
$9.76 - $13.19 $6.28 Million - $8.49 Million
643,343 Added 474.36%
778,965 $9.1 Million
Q2 2023

Aug 10, 2023
BUY
$7.09 - $10.08 $961,559 - $1.37 Million
135,622 New
135,622 $1.37 Million

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.83B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email